Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 25, 2015
May 6, 2020
5935b91f-6e77-42d4-81df-3b62cf000873
Related Documents
Analytical Procedures and Methods Validation for Drugs and Biologics
Guidance DocumentJuly 27, 2015Center for Drug Evaluation and Research
CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports
Guidance DocumentDecember 9, 2021Center for Drug Evaluation and Research
Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentDecember 10, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.